Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Phase 2 Trial of Salvage Chemotherapy with Temozolomide in Combination with Topotecan for Primary CNS Lymphoma.

		Keywords:		Temodar, Topotecan

		Phase:		Phase 2

		Treatment ID#s:		VT1510 NCT00109798

		Age Group:		Adults Only

		Min Karnofsky Score:		50: Requires considerable assistance and frequent medical care

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Patients must have either failed (relapse, progress or failed to achieve complete remission) high-dose systemic methotrexate, or be considered not candidates for high-dose systemic methotrexate. Patients must have radiographically measurable tumor Patients must have histopathologic documentation of Primary CNS Lymphoma at the time of initial diagnosis

		Last Updated:		11/27/2005

		Tumor Types:		Lymphomas


		Comments:

		Treatment Type:		Chemotherapy.

		Contact:		U. Of Texas Health Science Center At San Antonio Pamela Z. New, MD Contact: Pamela Z. New, MD Dept. Medicine / Neurology 7703 Floyd Curl Dr San Antonio, TX 78229- Phone:(210)617-5161 Fax: (210-567-4659 Click here to send an email Website: www.nabtt.org/texas.html

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By